Provided by Tiger Trade Technology Pte. Ltd.

COMPASS Pathways plc

6.57
-0.1700-2.52%
Volume:651.95K
Turnover:4.31M
Market Cap:630.83M
PE:-2.40
High:6.84
Open:6.80
Low:6.52
Close:6.74
52wk High:7.13
52wk Low:2.25
Shares:96.02M
Float Shares:58.41M
Volume Ratio:0.82
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7367
EPS(LYR):-2.2987
ROE:-205.81%
ROA:-38.43%
PB:16.78
PE(LYR):-2.86

Loading ...

Compass Pathways Hosts Webinar on Commercial Preparations for TRD and PTSD Clinical Trials

Reuters
·
Dec 09

Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression (Trd) and Clinical Trial Plans for Post-Traumatic Stress Disorder (Ptsd) on January 7, 2026, 10:00Am Et

THOMSON REUTERS
·
Dec 09

Compass Pathways to Join Evercore and Piper Sandler Healthcare Conferences

Reuters
·
Nov 20

Compass Pathways Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Nov 06

RBC Adjusts Price Target on COMPASS Pathways to $16 From $15, Maintains Outperform Rating

MT Newswires Live
·
Nov 05

Compass Pathways to Participate in Stifel 2025 Healthcare Conference

Reuters
·
Nov 05

Stock Track | Compass Pathways Plunges 5.28% After Reporting Larger-Than-Expected Q3 Loss

Stock Track
·
Nov 05

BUZZ-U.S. STOCKS ON THE MOVE-Hims & Hers Health, Hertz Global, Metsera

Reuters
·
Nov 04

Compass Pathways PLC reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 04

Compass Pathways Unveils Investor Presentation Highlighting Progress in Psilocybin Therapy for Depression and PTSD

Reuters
·
Nov 04

BUZZ-Compass Pathways jumps as it speeds up launch plans for depression drug

Reuters
·
Nov 04

Biotech firm Compass Pathways' operating income beats Q3 analyst expectations

Reuters
·
Nov 04

Stock Track | COMPASS Pathways Soars 11.60% Pre-market on Accelerated Commercialization Plans for COMP360

Stock Track
·
Nov 04

Compass Pathways Q3 EPS $(1.44) Misses $(0.38) Estimate

Benzinga
·
Nov 04

BRIEF-COMPASS Pathways Q3 EPS USD -1.44

Reuters
·
Nov 04

Compass Pathways reports Q3 2025 results with cash position of $185.9 million

Reuters
·
Nov 04

Compass Pathways: Accelerating Commercialization Readiness Plans for Comp360 by 9-12 Months

THOMSON REUTERS
·
Nov 04

Compass Pathways: Disclosure of 26-Week (Part B) Comp006 Data Expected in Early Q3 2026

THOMSON REUTERS
·
Nov 04

Compass Pathways Q3 Pretax Profit USD -137.947 Million

THOMSON REUTERS
·
Nov 04

Press Release: Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months

Dow Jones
·
Nov 04